Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features

Marco Rainer Kesting, Holger Sudhoff, Rafael Johannes Hasler, Markus Nieberler, Christoph Pautke, Klaus Dietrich Wolff, Stefan Wagenpfeil, Sammy Al-Benna, Frank Jacobsen, Lars Steinstraesser

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Proteomic analysis recently suggested aberrant psoriasin (S100A7) expression in oral squamous cell carcinoma (OSCC). In this study, OSCC specimens and matching normal oral tissues from 45 patients who had undergone ablative surgery were examined. Increased psoriasin expression at mRNA level was observed in OSCC samples by quantitative real-time RT-PCR (p = 0.015). Immunoflourescence analysis with psoriasin antibody confirmed these observations. Moreover, significantly increased mRNA ratios between malignant and normal samples were correlated with early UICC stage (p = 0.006), T1/T2 tumour classification (p = 0.043), absence of cervical lymph node metastasis (p = 0.027) and age under 65 (p = 0.009). Additionally, well-differentiated tumour tissues demonstrated a significantly higher psoriasin expression than moderate and poor differentiated carcinomas (p = 0.018). Based on this data, we conclude that psoriasin is a positive marker for oral cancerogenesis and early tumour progression.

Original languageEnglish
Pages (from-to)731-736
Number of pages6
JournalOral Oncology
Volume45
Issue number8
DOIs
StatePublished - Aug 2009
Externally publishedYes

Keywords

  • Age
  • Clinicopathologic correlation
  • Oral squamous cell carcinoma
  • Psoriasin
  • Recurrence
  • S100A7
  • Stage

Fingerprint

Dive into the research topics of 'Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features'. Together they form a unique fingerprint.

Cite this